The FDA is facing actions seeking to revoke mifepristone's approval, challenging the mail-order policy, and pausing related lawsuits.

The entities involved

• FDA →
  • Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
  • A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56
• Florida →

  state of the United States of America

  • Joint reporting by local media outlets exposed industry issues and highlighted the role of local companies in the Florida insurance market.Mon 15:00
  • The article covers three concurrent stories: Brightline facing financial strain, FPL offering bill credits to seniors, and Florida's wage hike attracting workers from Alabama.Mon 13:58
• Texas →

  Japanese owarai tarento

  • New World screwworm cases are confirmed in New Mexico and Texas, leading to intensified border surveillance and involving USDA Undersecretary Scott Hutchins.Sun 21:17
  • Vital Farms, Inc. is headquartered in Texas, and Lake Street reiterated a Buy rating on the company's stock.Sun 11:39
• Reed O'Connor →

  United States federal judge

  Nothing else this week.

Related events

• The FDA is facing actions seeking to revoke mifepristone's approval, challenging the mail-order policy, and pausing related lawsuits.Sep 9
• The FDA is currently reviewing concerns regarding mail-order abortion pills and the circulation of mifepristone.Jun 24
• Litigation regarding FDA approval process.Sep 2